作者: de Jonge Mj , Eskens Fa , Verweij J
DOI:
关键词:
摘要: In recent years developments in molecular biology have greatly increased our knowledge about the cellular processes which govern development of cancer. This has led to anticancer agents that specifically target one these processes, for example, farnesyl transferase inhibitors, receptor tyrosine kinase matrix metalloproteinase inhibitors and anti-angiogenic agents. addition this, new chemotherapeutic with specificity been developed. Finally, there an emphasis on developing forms administration so optimal use can be made existing